AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
66.11
-0.48 (-0.72%)
At close: Apr 28, 2026, 4:00 PM EDT
66.82
+0.71 (1.07%)
After-hours: Apr 28, 2026, 7:57 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.90 billion as of April 28, 2026. Its market cap has increased by 260.98% in one year.
Market Cap
1.90B
Enterprise Value
1.88B
1-Year Change
260.98%
Ranking
Category
Stock Price
$66.11
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.90B, an increase of 515.66%. That is a compound annual growth rate of 21.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.90B | 41.59% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.00B |
| Capricor Therapeutics | 1.97B |
| Trevi Therapeutics | 1.94B |
| Inhibrx Biosciences | 1.91B |
| Galapagos NV | 1.87B |
| Syndax Pharmaceuticals | 1.86B |
| Pharvaris | 1.85B |
| Vericel | 1.82B |